Publications

January 2018
Article

The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial

By: Leslie K. John, Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein and Kevin Volpp

Purpose: We tested the effects of employer subsidies on employee enrollment, attendance, and weight loss in a nationally-available weight management program.
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details

Keywords: Affordable Care Act (ACA); Subsidies; Weight Loss; Obesity; Incentives; Behavioral Economics; Motivation and Incentives; Behavior; Health Disorders; Health Care and Treatment; Compensation and Benefits; United States

01 Dec 2007
News

Where Are the Innovators in Health Care?

breaks the backs of U.S. firms that compete with companies in countries spending, at most, 12 percent of GDP on health care. Yet, despite this torrent of cash, more than 40... View Details

Keywords: Regina E. Herzlinger; Health, Social Assistance; Management

Article

Germany's Digital Health Reforms in the COVID-19 Era: Lessons and Opportunities for Other Countries

By: Sara Gerke, Ariel D. Stern and Timo Minssen

Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. Germany’s new Digital Healthcare Act (Digitale–Versorgung–Gesetz or DVG) entitles all individuals... View Details

Keywords: COVID-19; Reimbursement; Digital Health Reforms; Health Pandemics; Health Care and Treatment; Internet and the Web; Governing Rules, Regulations, and Reforms; Germany

01 Jun 2009
Lessons from the Classroom

The Challenges of Investing in Science-Based Innovation

she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that... View Details

Keywords: by Julia Hanna; Banking; Auto; Pharmaceutical

05 Jun 2019
Research & Ideas

If Your Customers Don't Care What You Charge, What Should You Charge?

found, in the retail gas markets they studied, was that accounting for increased consumer inertia led to an estimated 3.3 percent post-merger price increase, compared with the... View Details

Keywords: by Kristen Senz; Energy

July 2019
Article

The Impact of Price Regulation on the Availability of New Drugs in Germany

By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari

The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details

Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany

June 2020
Article

Waiting to Inhale: Reducing Stigma in the Medical Cannabis Industry

By: Kisha Lashley and Timothy G. Pollock

When a new industry category is predicated on a product or activity subject to ‘‘core’’ stigma—meaning its very nature is stigmatized—the actors trying to establish it may struggle to gain the resources they need to survive and grow. To explain the process of reducing... View Details

Keywords: Stigma; Cannabis Industry; Deviance; Public Opinion; Moral Sensibility; Health Care and Treatment

Register to Read

Article

Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment

By: Regina E. Herzlinger and Eugene Schneller

U.S. healthcare delivery has not benefitted from the same productivity growth as many other service industries, such as bricks and mortar retailing, a loss that has gravely diminished cost control and access. Regulatory capture, which creates barriers to venture... View Details

Keywords: Health Care; COVID-19; Regulation; Health Care and Treatment; Health Pandemics; Governing Rules, Regulations, and Reforms; Investment

02 Sep 2002
Research & Ideas

Foreign Multinationals in the U.S.: A Rocky Road

European, Japanese, and U.S. scholars to discuss the experience of foreign firms in the U.S. over View Details

Keywords: by Sarah Jane Johnston & Martha Lagace

January 2011 (Revised June 2011)
Case

Fixed Income Arbitrage in a Financial Crisis (A): US Treasuries in November 2008

Investment manager James Franey confronts an apparent arbitrage opportunity during the global financial crisis of 2008 when he notices a wide yield spread between two U.S. Treasury bonds that mature on the same date. Franey must decide if there is an opportunity, how... View Details

Keywords: Bonds; Valuation; Interest Rates; Financial Crisis; Financial Services Industry; United States

10 Sep 2019
News

New Survey Shows U.S. Businesses Taking Steps to Foster Culture Of Health, But Room to Grow

May 2009 (Revised August 2013)
Case

The DiagnoFirst Opportunity

By: Robert C. Pozen and Rukmini Balu

John Mason, a principle at Oldwell Partners, was facing a decision of whether or not to invest in DiagnoFirst, a molecular diagnostics firm. DiagnoFirst's key product was a genetic test that identified a subset of prostate cancer patients with a high risk of clinical... View Details

Keywords: Genetic Engineering; Genetically Modified; Genomics; Venture Capital; Patents; Genetics; Decision Choices and Conditions; Laws and Statutes; Investment; Science-Based Business; Biotechnology Industry

August 14, 2020
Comment

How Has COVID-19 Affected Health Insurance Offered by Small Businesses in the U.S.? Early Evidence from a Survey

By: Leemore S. Dafny, Yin Wei Soon, Zoë Cullen and Christopher T. Stanton

As the COVID-19 pandemic stretches toward its third quarter, loss of health insurance coverage has not figured prominently in the public debate. Data in this report demonstrate why that is, but also suggest that the apparent stability is fragile, with potentially... View Details

Keywords: Health Pandemics; Health Care and Treatment; Insurance; Small Business; Surveys; United States

Register to Read

04 Oct 2018
News

Precision medicine needs a business mindset in order to flourish

Article

Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users

By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt

Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details

Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States

28 Jan 2021
News

Lessons from the U.S.’s Rocky Vaccine Rollout

August 2010 (Revised March 2012)
Case

The UCLA Medical Center: Kidney Transplantation

By: Michael E. Porter, Jennifer F Baron, Jacob Mathew Chacko and Robin Jian Tang

In 2010, organ transplantation remained among the few sets of medical conditions in the U.S. for which bundled payments were a dominant reimbursement model, and for which patient health outcomes were universally measured and reported. In 1986, UCLA Medical Center was... View Details

Keywords: Insurance; Health Care and Treatment; Health Disorders; Measurement and Metrics; Outcome or Result; Competitive Strategy; Integration; Health Industry; California

November 2019
Article

A Review of Bundled Payments in Total Joint Replacement

By: Olivia Manickas-Hill, Kevin J. Bozic and Thomas W. Feeley

The Bundled Payments for Care Improvement (BPCI) initiative, developed by the U.S. Center for Medicare & Medicaid Innovation, aims to reduce health care expenditures while maintaining or improving patient outcomes.
Several published reports evaluating the impact... View Details

Keywords: Bundled Payments; Health Care and Treatment; Cost Management